RS51526B - Jedinjenja imidazolidinonil aminopirimidina za lečenje kancera - Google Patents

Jedinjenja imidazolidinonil aminopirimidina za lečenje kancera

Info

Publication number
RS51526B
RS51526B RSP-2010/0547A RSP20100547A RS51526B RS 51526 B RS51526 B RS 51526B RS P20100547 A RSP20100547 A RS P20100547A RS 51526 B RS51526 B RS 51526B
Authority
RS
Serbia
Prior art keywords
ethyl
fluoro
imidazolidin
ylamino
benzo
Prior art date
Application number
RSP-2010/0547A
Other languages
English (en)
Serbian (sr)
Inventor
Hong-Yu Li
Harold Burns Brooks
Joyce Z. Crich
James Robert Henry
Jason Scott Sawyer
Yan Wang
Original Assignee
Eli Lilly & Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly & Company filed Critical Eli Lilly & Company
Publication of RS51526B publication Critical patent/RS51526B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
RSP-2010/0547A 2006-12-21 2007-12-11 Jedinjenja imidazolidinonil aminopirimidina za lečenje kancera RS51526B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87132206P 2006-12-21 2006-12-21

Publications (1)

Publication Number Publication Date
RS51526B true RS51526B (sr) 2011-06-30

Family

ID=39185681

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2010/0547A RS51526B (sr) 2006-12-21 2007-12-11 Jedinjenja imidazolidinonil aminopirimidina za lečenje kancera

Country Status (21)

Country Link
US (1) US8063212B2 (cg-RX-API-DMAC10.html)
EP (1) EP2125794B1 (cg-RX-API-DMAC10.html)
JP (1) JP2010513553A (cg-RX-API-DMAC10.html)
KR (1) KR101080594B1 (cg-RX-API-DMAC10.html)
CN (1) CN101568539B (cg-RX-API-DMAC10.html)
AT (1) ATE485291T1 (cg-RX-API-DMAC10.html)
AU (1) AU2007334040B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0720607A2 (cg-RX-API-DMAC10.html)
CA (1) CA2673564A1 (cg-RX-API-DMAC10.html)
CY (1) CY1110950T1 (cg-RX-API-DMAC10.html)
DE (1) DE602007010041D1 (cg-RX-API-DMAC10.html)
DK (1) DK2125794T3 (cg-RX-API-DMAC10.html)
EA (1) EA016178B1 (cg-RX-API-DMAC10.html)
ES (1) ES2351371T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20100641T1 (cg-RX-API-DMAC10.html)
MX (1) MX2009006635A (cg-RX-API-DMAC10.html)
PL (1) PL2125794T3 (cg-RX-API-DMAC10.html)
PT (1) PT2125794E (cg-RX-API-DMAC10.html)
RS (1) RS51526B (cg-RX-API-DMAC10.html)
SI (1) SI2125794T1 (cg-RX-API-DMAC10.html)
WO (1) WO2008076705A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101628B2 (en) 2006-12-21 2012-01-24 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
EA016781B1 (ru) * 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
ES2563861T3 (es) 2012-06-14 2016-03-16 Daiichi Sankyo Company, Limited Derivado de piperidinilpirazolopiridina
EP2929883A1 (en) 2014-04-08 2015-10-14 Institut Pasteur Pyrazole derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors
KR102693614B1 (ko) 2022-04-04 2024-08-08 경희대학교 산학협력단 나프탈렌-2-일알킬기가 치환된 이미다졸리움 유도체 및 이를 유효성분으로 포함하는 암 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) * 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
AU2005316312B2 (en) * 2004-12-17 2009-10-22 Amgen, Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
US8101628B2 (en) 2006-12-21 2012-01-24 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
EA016781B1 (ru) 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds

Also Published As

Publication number Publication date
WO2008076705A1 (en) 2008-06-26
HRP20100641T1 (hr) 2010-12-31
US8063212B2 (en) 2011-11-22
SI2125794T1 (sl) 2011-02-28
DE602007010041D1 (de) 2010-12-02
JP2010513553A (ja) 2010-04-30
KR101080594B1 (ko) 2011-11-04
EA200970616A1 (ru) 2009-10-30
EP2125794A1 (en) 2009-12-02
AU2007334040B2 (en) 2012-02-16
EP2125794B1 (en) 2010-10-20
CA2673564A1 (en) 2008-06-26
MX2009006635A (es) 2009-06-30
ATE485291T1 (de) 2010-11-15
ES2351371T3 (es) 2011-02-03
CN101568539A (zh) 2009-10-28
US20100081641A1 (en) 2010-04-01
KR20090086111A (ko) 2009-08-10
CY1110950T1 (el) 2015-06-10
DK2125794T3 (da) 2011-01-24
CN101568539B (zh) 2012-04-25
BRPI0720607A2 (pt) 2014-04-08
EA016178B1 (ru) 2012-02-28
PL2125794T3 (pl) 2011-04-29
AU2007334040A1 (en) 2008-06-26
PT2125794E (pt) 2011-01-10

Similar Documents

Publication Publication Date Title
KR101131261B1 (ko) 트리아졸릴 아미노피리미딘 화합물
AU2007334040B2 (en) Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
AU2008254318B2 (en) Triazolyl aminopyrimidine compounds
JP5166441B2 (ja) 癌治療用イミダゾリジノニルアミノピリミジン化合物